Health Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, May 30, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jason Alger, Chief Financial Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences:
- The Stifel Cross Sector Insight Conference, being held in Boston, including a fireside chat on Tuesday, June 4, 2024, at 9:45am ET.
- The Goldman Sachs 45th Annual Global Healthcare Conference, being held in Miami, including a presentation on Wednesday, June 12, 2024, at 8:40am ET.
About Health Catalyst
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its clients leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.
Health Catalyst Investor Relations Contact:
Jack Knight
Vice President, Investor Relations
+1 (855)-309-6800
[email protected]
Health Catalyst Media Contact:
Tarah Neujahr Bryan
Chief Marketing Officer
[email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rakovina Therapeutics Announces Results from 2026 Annual General Meeting
- Form 8.5 (EPT/RI)-Gamma Communications Plc
- NEWS RELEASE OMNI-LITE INDUSTRIES REPORTS SECOND QUARTER AND YEAR-TO-DATE FISCAL 2026 RESULTS
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Stifel, Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share